<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.3 20210610//EN" "JATS-journalpublishing1-3.dtd">
<article article-type="research-article" dtd-version="1.3" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xml:lang="ru"><front><journal-meta><journal-id journal-id-type="publisher-id">scbmt</journal-id><journal-title-group><journal-title xml:lang="ru">БИОМЕДИЦИНА</journal-title><trans-title-group xml:lang="en"><trans-title>Journal Biomed</trans-title></trans-title-group></journal-title-group><issn pub-type="ppub">2074-5982</issn><issn pub-type="epub">2713-0428</issn><publisher><publisher-name>Scientific center of biomedical technologies of Federal Medical and Biological Agency</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="doi">10.33647/2713-0428-17-3E-176-182</article-id><article-id custom-type="elpub" pub-id-type="custom">scbmt-1337</article-id><article-categories><subj-group subj-group-type="heading"><subject>Research Article</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="ru"><subject>БИОМЕДИЦИНСКИЕ ТЕХНОЛОГИИ В КЛИНИЧЕСКИХ ИССЛЕДОВАНИЯХ</subject></subj-group><subj-group subj-group-type="section-heading" xml:lang="en"><subject>BIOMEDICAL TECHNOLOGIES IN CLINICAL RESEARCH</subject></subj-group></article-categories><title-group><article-title>Биоинформационный анализ уровня остеомаркеров в десневой жидкости при системном остеопорозе и местных остеодеструктивных процессах дентоальвеолярной области</article-title><trans-title-group xml:lang="en"><trans-title>Bioinformatical analysis of the level of osteomarkers in the gingival fluid in systemic osteoporosis and local osteo-destructive processes in the dentoalveolar region</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Сафроненко</surname><given-names>А. В.</given-names></name><name name-style="western" xml:lang="en"><surname>Safronenko</surname><given-names>A. V.</given-names></name></name-alternatives><bio xml:lang="ru"><p>д.м.н., доц., </p><p>344022, Ростов-на-Дону, Нахичеванский пер., 29</p></bio><bio xml:lang="en"><p>Cand. Sci. (Med.), Assoc. Prof., </p><p>344022, Rostov-on-Don, Nakhichevanskiy Lane, 29</p></bio><email xlink:type="simple">andrejsaf@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Косенко</surname><given-names>В. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Kosenko</surname><given-names>V. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>344022, Ростов-на-Дону, Нахичеванский пер., 29</p></bio><bio xml:lang="en"><p>344022, Rostov-on-Don, Nakhichevanskiy Lane, 29</p></bio><email xlink:type="simple">kosenkovla@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Айрапетов</surname><given-names>Г. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Airapetov</surname><given-names>G. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>344037, Ростов-на-Дону, 14-я линия, 63</p></bio><bio xml:lang="en"><p>344037, Rostov-on-Don, 14th Line, 63</p></bio><email xlink:type="simple">stomat@mail.ru</email><xref ref-type="aff" rid="aff-2"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Демидов</surname><given-names>И. А.</given-names></name><name name-style="western" xml:lang="en"><surname>Demidov</surname><given-names>I. A.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., </p><p>344022, Ростов-на-Дону, Нахичеванский пер., 29</p></bio><bio xml:lang="en"><p>Cand. Sci. (Med.),</p><p>344022, Rostov-on-Don, Nakhichevanskiy Lane, 29</p></bio><email xlink:type="simple">demidova-66@yandex.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Нажева</surname><given-names>М. И.</given-names></name><name name-style="western" xml:lang="en"><surname>Nazheva</surname><given-names>M. I.</given-names></name></name-alternatives><bio xml:lang="ru"><p>к.м.н., доц.,</p><p>344022, Ростов-на-Дону, Нахичеванский пер., 29</p></bio><bio xml:lang="en"><p>Cand. Sci. (Med.), Assoc. Prof., </p><p>344022, Rostov-on-Don, Nakhichevanskiy Lane, 29</p></bio><email xlink:type="simple">nazheva@mail.ru</email><xref ref-type="aff" rid="aff-1"/></contrib><contrib contrib-type="author" corresp="yes"><name-alternatives><name name-style="eastern" xml:lang="ru"><surname>Поляков</surname><given-names>В. М.</given-names></name><name name-style="western" xml:lang="en"><surname>Polyakov</surname><given-names>V. M.</given-names></name></name-alternatives><bio xml:lang="ru"><p>344022, Ростов-на-Дону, Нахичеванский пер., 29</p></bio><bio xml:lang="en"><p>344022, Rostov-on-Don, Nakhichevanskiy Lane, 29</p></bio><email xlink:type="simple">polyakovvalm@rambler.ru</email><xref ref-type="aff" rid="aff-1"/></contrib></contrib-group><aff-alternatives id="aff-1"><aff xml:lang="ru"><institution>ФГБОУ ВО «Ростовский государственный медицинский университет» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>Rostov State Medical University of the Ministry of Health Сare of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><aff-alternatives id="aff-2"><aff xml:lang="ru"><institution>ФГБУ «Национальный медицинский исследовательский центр онкологии» Минздрава России</institution><country>Россия</country></aff><aff xml:lang="en"><institution>National Medical Research Center of Oncology of the Ministry of Health Сare of Russia</institution><country>Russian Federation</country></aff></aff-alternatives><pub-date pub-type="collection"><year>2021</year></pub-date><pub-date pub-type="epub"><day>26</day><month>10</month><year>2021</year></pub-date><volume>17</volume><issue>3E</issue><fpage>176</fpage><lpage>182</lpage><permissions><copyright-statement>Copyright &amp;#x00A9; Сафроненко А.В., Косенко В.А., Айрапетов Г.А., Демидов И.А., Нажева М.И., Поляков В.М., 2021</copyright-statement><copyright-year>2021</copyright-year><copyright-holder xml:lang="ru">Сафроненко А.В., Косенко В.А., Айрапетов Г.А., Демидов И.А., Нажева М.И., Поляков В.М.</copyright-holder><copyright-holder xml:lang="en">Safronenko A.V., Kosenko V.A., Airapetov G.A., Demidov I.A., Nazheva M.I., Polyakov V.M.</copyright-holder><license xml:lang="ru" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>Данная работа распространяется под лицензией Creative Commons Attribution 4.0.</license-p></license><license xml:lang="en" license-type="creative-commons-attribution" xlink:href="https://creativecommons.org/licenses/by/4.0/" xlink:type="simple"><license-p>This work is licensed under a Creative Commons Attribution 4.0 License.</license-p></license></permissions><self-uri xlink:href="https://journal.scbmt.ru/jour/article/view/1337">https://journal.scbmt.ru/jour/article/view/1337</self-uri><abstract><p>На 57 больных и 15 практически здоровых людях проанализирована информативность оценки биохимических маркеров в десневой жидкости при системных и местных изменениях костной ткани различного генеза. Выделены три группы больных: группа 1 — 20 пациентов с язвенным колитом и стероидным остеопорозом вследствие терапии глюкокортикоидами; группа 2 — 22 пациента, у которых диагностирован рак слизистой оболочки дна полости рта с эрозией кортикальной кости либо зубной лунки первичной опухолью; группа 3 — 15 человек со среднетяжёлым дентальным периимплантитом. В качестве исследуемого материала использовали десневую жидкость. Определяли содержание катепсина К, тартрат-резистентной кислой фосфатазы, костной фракции щелочной фосфатазы. Установлено, что при стероидном остеопорозе из трёх исследуемых маркеров в десневой жидкости статистически значимо повышался уровень катепсина К. В группе 2 при опухолевой остеодеструкции в десневой жидкости наблюдался десятикратный прирост концентрации катепсина К и ТРКФ на фоне умеренного повышения содержания костной фракции щелочной фосфатазы. При остеодеструкции, сопряжённой с воспалительными дентоальвеолярными процессами, имело место умеренное повышение концентрации катепсина К и тартрат-резистентной кислой фосфатазы. Таким образом, определение остеомаркеров в десневой жидкости информативно для разграничения системных и местных изменений структуры костной ткани. </p></abstract><trans-abstract xml:lang="en"><p>The informational value of assessing biochemical markers in the gingival fluid of patients with various systemic and local changes in bone tissue was analyzed in a sample of 57 patients and 15 healthy people. The patients were differentiated into 3 groups: 1) 20 patients with ulcerative colitis and steroid osteoporosis due to glucocorticoid therapy; 2) 22 patients diagnosed with cancer of the mucous membrane of the floor of the mouth with erosions of the cortical bone or dental socket by a primary tumor; 3) 15 patients with moderate dental peri-implantitis. Gingival fluid was used as a test material. The content of cathepsin K, tartrate-resistant acid phosphatase, and bone fraction of alkaline phosphatase was determined. In steroidal osteoporosis, the cathepsin K level in the gingival fluid was found to be statistically significantly increased compared to other markers under study. In group 2, with tumor osteodestruction in the gingival fluid, a 10-fold increase in the concentration of cathepsin K and tartrate-resistant acid phosphatase was observed against the background of a moderate increase in the bone fraction of alkaline phosphatase content. In osteodestruction associated with inflammatory dentoalveolar processes, a moderate increase in the concentration of cathepsin K and tartrate-resistant acid phosphatase was observed. Thus, the determination of osteomarkers in the gingival fluid can be considered informative in terms of distinguishing between systemic and local changes in the structure of bone tissue. </p></trans-abstract><kwd-group xml:lang="ru"><kwd>остеопороз</kwd><kwd>остеомаркеры</kwd><kwd>глюкокортикостероиды</kwd><kwd>рак слизистой оболочки полости рта</kwd><kwd>десневая жидкость</kwd></kwd-group><kwd-group xml:lang="en"><kwd>osteoporosis</kwd><kwd>osteomarkers</kwd><kwd>glucocorticosteroids</kwd><kwd>cancer of the oral mucosa</kwd><kwd>gingival fluid</kwd></kwd-group></article-meta></front><back><ref-list><title>References</title><ref id="cit1"><label>1</label><citation-alternatives><mixed-citation xml:lang="ru">Гончаров И.Ю., Ломакин М.В., Козлова М.В., Гончаров Ю.И. Особенности архитектоники подбородочного отдела нижней челюсти и применение методов лучевой диагностики для их объективизации. Российский вестник дентальной имплантологии. 2013;1(27):14–22.</mixed-citation><mixed-citation xml:lang="en">Goncharov I.Yu., Lomakin M.V., Kozlova M.V., Goncharov Yu.I. Osobennosti arkhitektoniki podborodochnogo otdela nizhney chelyusti i primenenie metodov luchevoy diagnostiki dlya ikh ob”ektivizatsii [Features of the architectonics of the chin of the lower jaw and the use of methods of radiation diagnostics for their objectivity]. Rossijskij vestnik dental’noj implantologii [Russian Bulletin of Dental Implantology]. 2013;1(27):14–22. (In Russian).</mixed-citation></citation-alternatives></ref><ref id="cit2"><label>2</label><citation-alternatives><mixed-citation xml:lang="ru">Зорина О.А., Амхадова М.А., Хамукова А.А., Алескеров Э.Ш., Айрапетов Г.А., Демидова А.А. Особенности остеоиммунологических аспектов остеорезорбции при периимплантите, хроническом пародонтите и раке альвеолярного отростка и альвеолярной части челюстей. Стоматология. 2020;99(4):27–32. DOI: 10.17116/stomat20209904127.</mixed-citation><mixed-citation xml:lang="en">Zorina O.A., Amhadova M.A., Hamukova A.A., Aleskerov E.Sh., Ajrapetov G.A., Demidova A.A. Osobennosti osteoimmunologicheskikh aspektov osteorezorbtsii pri periimplantite, khronicheskom parodontite i rake al’veolyarnogo otrostka i al’veolyarnoy chasti chelyustey [Osteoimmunological aspects of periodontal inflammatory destructive changes at periimplantitis, chronic periodontitis and oncological diseases of the oral cavity]. Stomatology. 2020;99(4):27–32. (In Russian). DOI: 10.17116/stomat20209904127.</mixed-citation></citation-alternatives></ref><ref id="cit3"><label>3</label><citation-alternatives><mixed-citation xml:lang="ru">Любимова Н.В., Кушлинский Н.Е. Биохимические маркеры метастазирования в кости. Успехи молекулярной онкологии. 2015;1(2):61–75. DOI: 10.17650/2313-805X.2015.2.1.061-075.</mixed-citation><mixed-citation xml:lang="en">Lyubimova N.V., Kushlinskij N.E. Biokhimicheskie markery metastazirovaniya v kosti [Biochemical markers of bone metastasis]. Uspekhi molekulyarnoj onkologii [Advances in molecular oncology]. 2015;1(2):61–75. (In Russian). DOI: 10.17650/2313-805X.2015.2.1.061-075.</mixed-citation></citation-alternatives></ref><ref id="cit4"><label>4</label><citation-alternatives><mixed-citation xml:lang="ru">Цориев Т.Т., Белая Ж.Е., Рожинская Л.Я., Мельниченко Г.А., Ильин А.В., Никанкина Л.В., Дедов И.И. Новые биомаркеры регуляции костного ремоделирования при акромегалии и эндогенном гиперкортицизме. Ожирение и метаболизм. 2018;15(3):33–41. DOI: 10.14341/OMET9447.</mixed-citation><mixed-citation xml:lang="en">Tsoriev T.T., Belaya Z.E., Rozhinskaya L.Ya., Mel’nichenko G.A., Ilyin A.V., Nikankina L.V., Dedov I.I. Novye biomarkery regulyatsii kostnogo remodelirovaniya pri akromegalii i endogennom giperkortitsizme [New biomarkers of bone remodelling regulation in patients with acromegaly and endogenous hypercortisolism]. Ozhirenie i metabolism [Obesity and Metabolism]. 2018;15(3):33–41. (In Russian). DOI: 10.14341/OMET9447.</mixed-citation></citation-alternatives></ref><ref id="cit5"><label>5</label><citation-alternatives><mixed-citation xml:lang="ru">Bessueille L., Mebarek S., Briolay A., Gleizes M. Tissue-nonspecific alkaline phosphatase is an anti-inflammatory nucleotidase. Bone. 2020;133:115262. DOI: 10.1016/j.bone.2020.115262.</mixed-citation><mixed-citation xml:lang="en">Bessueille L., Mebarek S., Briolay A., Gleizes M. Tissue-nonspecific alkaline phosphatase is an anti-inflammatory nucleotidase. Bone. 2020;133:115262. DOI: 10.1016/j.bone.2020.115262.</mixed-citation></citation-alternatives></ref><ref id="cit6"><label>6</label><citation-alternatives><mixed-citation xml:lang="ru">Bishop N. Bone material properties in osteogenesis imperfecta. J. Bone Miner Res. 2016;31(4):699–708. DOI: 10.1002/jbmr.2835.</mixed-citation><mixed-citation xml:lang="en">Bishop N. Bone material properties in osteogenesis imperfecta. J. Bone Miner Res. 2016;31(4):699–708. DOI: 10.1002/jbmr.2835.</mixed-citation></citation-alternatives></ref><ref id="cit7"><label>7</label><citation-alternatives><mixed-citation xml:lang="ru">Dai R., Wu Z., Chu H.Y., Lu J., Lyu A., Liu J., Zhang G. Cathepsin K: The action in and beyond bone. Front. Cell Dev. Biol. 2020;8:433. DOI: 10.3389/fcell.2020.00433.</mixed-citation><mixed-citation xml:lang="en">Dai R., Wu Z., Chu H.Y., Lu J., Lyu A., Liu J., Zhang G. Cathepsin K: The action in and beyond bone. Front. Cell Dev. Biol. 2020;8:433. DOI: 10.3389/fcell.2020.00433.</mixed-citation></citation-alternatives></ref><ref id="cit8"><label>8</label><citation-alternatives><mixed-citation xml:lang="ru">Drake M.T., Clarke B.L., Oursler M.J., Khosla S. Cathepsin K inhibitors for osteoporosis: Biology, potential clinical utility, and lessons learned. Endocr. Rev. 2017:38;325–350. DOI: 10.1210/er.2015-1114.</mixed-citation><mixed-citation xml:lang="en">Drake M.T., Clarke B.L., Oursler M.J., Khosla S. Cathepsin K inhibitors for osteoporosis: Biology, potential clinical utility, and lessons learned. Endocr. Rev. 2017:38;325–350. DOI: 10.1210/er.2015-1114.</mixed-citation></citation-alternatives></ref><ref id="cit9"><label>9</label><citation-alternatives><mixed-citation xml:lang="ru">Hu Y., Yu J., Wang Q., Zhang L., Chen X., Cao Y., Zhao J., Xu Y. Tartrate-resistant acid phosphatase 5/ACP5 interacts with p53 to control the expression of SMAD3 in lung adenocarcinoma. Molecular Therapy: Oncolytics. 2020:16;272–288. DOI: 10.1016/j.omto.2020.01.010.</mixed-citation><mixed-citation xml:lang="en">Hu Y., Yu J., Wang Q., Zhang L., Chen X., Cao Y., Zhao J., Xu Y. Tartrate-resistant acid phosphatase 5/ACP5 interacts with p53 to control the expression of SMAD3 in lung adenocarcinoma. Molecular Therapy: Oncolytics. 2020:16;272–288. DOI: 10.1016/j.omto.2020.01.010.</mixed-citation></citation-alternatives></ref><ref id="cit10"><label>10</label><citation-alternatives><mixed-citation xml:lang="ru">Takito J., Inoue S., Nakamura M. The sealing zone in osteoclasts: A self-organized structure on the bone. Int. J. Mol. Sci. 2018;19:984. DOI: 10.3390/ijms19040984.</mixed-citation><mixed-citation xml:lang="en">Takito J., Inoue S., Nakamura M. The sealing zone in osteoclasts: A self-organized structure on the bone. Int. J. Mol. Sci. 2018;19:984. DOI: 10.3390/ijms19040984.</mixed-citation></citation-alternatives></ref></ref-list><fn-group><fn fn-type="conflict"><p>The authors declare that there are no conflicts of interest present.</p></fn></fn-group></back></article>
